Bullish Case: "Moderate Buy" consensus recommendation [beststocks.com] and increasing stake by Rhumbline Advisers [beststocks.com] may signal positive growth for RGEN.


Show historical bullish cases

Bearish Case: Slight underperformance in quarterly earnings and a 23.3% decline in revenue YoY [beststocks.com], along with Sands Capital Management LLC selling 166588 shares [marketbeat.com] indicate potential concerns.


Show historical bearish cases

Takeaway: Despite its recent performance hiccups, RGEN has demonstrated potential for growth with bullish consensus, institutional backing, and upcoming corporate events. Monitor closely for developments in the near future.


Show historical takeaways

Potential Outcomes:

1) Increased investor confidence continues to drive stock higher (50%): Based on bullish consensus and increased investment by Rhumbline [beststocks.com][beststocks.com]. 2) Negative performance impacts the stock due to underwhelming financial results and bulk share sales by existing stakeholders (30%): Corporate actions by Sands Capital Management and reported underperformance [beststocks.com][marketbeat.com]. 3) RGEN’s presentation at Wells Fargo Healthcare Conference positively impacts the stock price (10%): Contingent on successful presentation and market reception [globenewswire.com]. 4) The partnership with Sartorius for bioreactor development leads to further growth (10%): Dependent on the success of the partnership [bioprocessintl.com].


September 07, 2023


Repligen Forecast

[RGEN]  Repligen
Price Forecast: NEUTRAL    Price Action: MEAN REVERTING



Access RGEN Forecasts + Optimized Trading Strategies.







RGEN Balanced News:




Access longer forecasts + daily optimized trades.


Correlated Stock Forecasts

Assets that tend to move strongly with RGEN



MOS Forecast + Options Trading Strategies   [MOS]  Mosaic (0.76)


WOLF Forecast + Options Trading Strategies   [WOLF]  Wolfspeed (0.73)


ARE Forecast + Options Trading Strategies   [ARE]  Alexandria Real Estate (0.68)


CRBU Forecast + Options Trading Strategies   [CRBU]  Caribou Biosciences (0.67)


SABR Forecast + Options Trading Strategies   [SABR]  Sabre (0.66)



Uncorrelated Stock Forecasts

Assets with little price relationship to RGEN



CAR Forecast + Options Trading Strategies   [CAR]  Avis Budget (0.02)


CENX Forecast + Options Trading Strategies   [CENX]  Century Aluminum (0.03)


MFA Forecast + Options Trading Strategies   [MFA]  MFA Financial (-0.04)


KNX Forecast + Options Trading Strategies   [KNX]  Knight-Swift Transportation (-0.05)


OIH Forecast + Options Trading Strategies   [OIH]  VanEck Vectors Oil Services (0.05)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against RGEN



DRI Forecast + Options Trading Strategies   [DRI]  Darden Restaurants (-0.59)


PG Forecast + Options Trading Strategies   [PG]  Procter & Gamble (-0.61)


SAP Forecast + Options Trading Strategies   [SAP]  Sap SE (-0.62)


FMX Forecast + Options Trading Strategies   [FMX]  Fomento Economico Mexicano S.A.B. de C.V. (-0.62)


CBOE Forecast + Options Trading Strategies   [CBOE]  Cboe Global Markets (-0.62)